SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently facing intense selling pressure, with community sentiment shifting between aggressive short-selling and debate over whether current price levels represent a structural breakdown or a buying opportunity. Discussions are dominated by concerns over crowded positioning, potential contract renewals, and skepticism regarding valuation, as participants closely monitor key support levels to determine if the stock is nearing a bottom.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion Inc. is trending following the White House's announcement of new executive orders focused on quantum sensing and networking, which positions the company as a key beneficiary in the quantum sector. Investors are actively discussing the stock's long-term potential, its upcoming Russell 3000 inclusion, and the impact of government-backed quantum initiatives on the broader technology landscape.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors debate the impact of leadership changes, including the upcoming departure of the CFO, while closely monitoring progress in the company's oncology pipeline following recent trial updates. Market participants are actively discussing the stock's long-term valuation and the effectiveness of current growth strategies in the competitive biotech landscape.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is drawing significant investor interest as shareholders bet on a long-term turnaround fueled by international expansion, a new CEO, and persistent buyout speculation involving major stakeholders. The community remains heavily focused on the stock's elevated short interest, with many retail traders actively discussing the potential for a short squeeze despite ongoing concerns regarding operational efficiency and food quality.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics (DFTX) is experiencing heightened investor interest driven by positive Phase 3 data for its MDD therapeutic and anticipation of a series of upcoming pivotal trial milestones. The community is actively debating the company's long-term commercialization prospects and the impact of a recent major public offering, with many investors weighing the potential for a breakthrough against the risks of dilution and the competitive landscape for psychedelic-based medicine.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors react to the company's roadmap for gate-model quantum simulators and potential expansion into government-backed quantum initiatives. The community remains highly polarized, with intense debate between long-term bulls betting on quantum supremacy and skeptics focused on high cash burn, heavy insider selling, and extreme valuation concerns.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. is seeing intense investor attention and increased trade volume following a significant purchase order for its NeuraWave photonic reservoir systems and broader sector momentum surrounding government-led quantum technology initiatives. The community remains highly focused on the company's hardware commercialization progress and the potential for a short squeeze, given the substantial short interest and heavy call option activity.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is drawing intense community focus as domestic policy shifts spotlight its role in national quantum computing and defense supply chains, fueling a debate between those betting on its long-term industrial moat and others questioning the pace of its legacy software transition. Traders are closely monitoring the stock's support levels while speculating on further government-backed equity or contract opportunities tied to its AI and quantum infrastructure.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is facing intense downward pressure as retail investors grapple with post-IPO volatility and concerns over its massive valuation relative to current revenue. The community is sharply divided, with many debating whether the stock is a long-term play on AI and space infrastructure or a temporary hype-driven rug pull that will see further declines before finding a floor.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is attracting significant retail and institutional interest as investors track substantial share accumulation by CEO Kevin Tang and speculate on a potential buyout. While the company maintains clinical progress and steady commercial performance, the community remains divided, weighing the upside of recent insider activity against long-standing frustration over management transparency and sluggish price movement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can ENSG's Acquisition Strategy Sustain Growth and Expansion?

Ensign Group is accelerating growth through acquisitions and operational gains, with record occupancy, rising revenue and capital ready for more deals.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Ensign Group, Inc. - ENSG

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Ensign Group, Inc. - ENSG INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Ensign Group, Inc. - ENSG PR Newswire NEW YORK, June 18, 2026 NEW YORK, June 18, 2026 /PRNewswire...

ENSG Class Action Investigation: BFA Announces it is Investigating Ensign for Securities Fraud after Regulatory Allegations in Reports Trigger 8% Stock Drop

Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into The Ensign Group, Inc. (NASDAQ:ENSG) for potential securities fraud after significant stock drops.If you invested in Ensign, you are encouraged to obtain additional information by visiting...

The Ensign Group (ENSG) Shares Fall Amid Activist Forensic Reports Challenging Patient Care Claims, Legal Compliance -- HBSS

The Ensign Group (ENSG) Shares Fall Amid Activist Forensic Reports Challenging Patient Care Claims, Legal Compliance -- HBSS The Ensign Group (ENSG) Shares Fall Amid Activist Forensic Reports Challenging Patient Care Claims, Legal Compliance -- HBSS PR Newswire SAN FRANCISCO, June 16, 2026 SAN...

Is ENSG's Expanded $100M Buyback Program a Positive for Investors?

Ensign Group boosts buyback capacity to $100M after strong Q1 2026 results, rising cash flow and higher earnings guidance signal confidence.

Here's Why Ensign Group (ENSG) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The Ensign Group (ENSG) Securities Fraud Investigation - Levi & Korsinsky

The Ensign Group (ENSG) Securities Fraud Investigation - Levi & Korsinsky The Ensign Group (ENSG) Securities Fraud Investigation - Levi & Korsinsky PR Newswire NEW YORK, June 16, 2026 Shares of The Ensign Group fell sharply after a short-seller report alleged systemic neglect, quality-measure...

Rosen Law Firm Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSG

Rosen Law Firm Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSG Rosen Law Firm Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSG PR Newswire NEW YORK, June 16, 2026 NEW YORK, June 16...

ENSG ALERT: Investigation Launched into The Ensign Group, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm

ENSG ALERT: Investigation Launched into The Ensign Group, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm ENSG ALERT: Investigation Launched into The Ensign Group, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm PR...

Securities Fraud Investigation Into The Ensign Group, Inc. (ENSG) Continues Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of The Ensign Group, Inc. (Ensign or the Company) (NASDAQ: ENSG) investors concerning the Companys possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO...

The Ensign Group, Inc. engages in providing skilled nursing, senior living, and rehabilitative care services. It operates through the Skilled Services and Standard Bearer segments. The Skilled Services segments includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment refers to the leasing to skilled nursing and senior living operations. The company was founded by Roy E. Christensen, Christopher R. Christensen, and Gregory K. Stapley in 1999 and is headquartered in San Juan Capistrano, CA.

Ensign Group Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$1.85	--	--	N/A
Q1 '26	$1.82	$1.85	1.79%	BEAT
Q4 '25	$1.77	$1.82	3.01%	BEAT
Q3 '25	$1.61	$1.64	1.70%	BEAT
Q2 '25	$1.55	$1.59	2.49%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

ENSGEnsign Group Inc

Upcoming Earnings: Q2 '26

Historical Earnings

Latest ENSG News